Nocera, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nocera, Inc. (Nasdaq: NCRA) on May 22, 2026. The filing discloses the entry into a material definitive agreement and amendments to existing financing arrangements. The Company is an emerging growth company incorporated in Nevada with principal executive offices in New Taipei City, Taiwan.
Key Financial Metrics and Agreements
The filing does not report specific revenue, profit, cash flow, or margin figures for a fiscal period. Instead, it details the following financial instruments and commitments:
- Equity Purchase Facility Agreement (EPFA): The Company entered into an agreement with an institutional investor to sell up to $100,000,000 of newly issued common stock over a 24-month period.
- Ownership Limitations: The Investor's ownership is capped at 4.99% of outstanding common stock (increasable to 9.99% with notice). Issuance is capped at 19.99% of outstanding shares unless stockholder approval is obtained.
- Securities Purchase Agreement Amendment: The Company amended a prior agreement regarding senior secured convertible notes. Proceeds from future closings are restricted to general corporate purposes, working capital, and strategic transactions.
- Prohibited Uses: Proceeds from the convertible notes cannot be used for debt repayment, share repurchases, related party payments, or litigation settlements (except acquisition-related).
Material Changes and Unusual Items
The primary material change is the establishment of the $100 million equity facility, providing the Company with discretionary access to capital without mandatory minimum purchase requirements or non-usage fees. Additionally, the amendment to the Securities Purchase Agreement clarifies and restricts the permissible use of proceeds from the senior secured convertible notes, explicitly prohibiting the repayment of general indebtedness.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the anticipated benefits of the EPFA and the ability to issue shares. Key risks and contingencies include:
- Termination Triggers: The EPFA will terminate if the Company makes a material restatement of financial statements for two or more consecutive fiscal quarters.
- Regulatory Approvals: The ability to issue shares beyond the 19.99% cap is contingent upon obtaining stockholder approval in accordance with Nasdaq rules.
- Market Conditions: The Company's ability to utilize the facility is subject to market conditions and the trading price of its common stock.
- Registration Timeline: The Company must file a registration statement for the resale of shares within 45 days and use best efforts to make it effective within 90 days.
Investor Verification Checklist
- Verify the specific pricing mechanisms for the Advance Shares under the EPFA (not detailed in the summary text).
- Confirm the current outstanding share count to calculate the exact number of shares issuable under the 19.99% Exchange Cap.
- Review the full text of the First Amendment to the Securities Purchase Agreement (Exhibit 10.3) for details on the remaining principal balance of the convertible notes.
- Monitor upcoming filings for the required stockholder approval vote regarding the issuance cap increase.
- Check for any material restatements of financial statements that could trigger immediate termination of the EPFA.